Wealth Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Wealth Group's BMY Position: Q2 2026 in Review
Wealth Group increased its Bristol-Myers Squibb (BMY) stake by 296% in Q2 2026, buying an estimated $588K and bringing the position to 13,692 shares worth $789K. The position accounts for 0.2% of the portfolio, ranked #68.
Wealth Group first reported a position in BMY in Q1 2024 and has held it in 6 quarters since. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Wealth Group held 13,692 shares of Bristol-Myers Squibb worth $789K as of Q2 2026.
- Wealth Group bought 10,234 Bristol-Myers Squibb shares in Q2 2026, an estimated $588K.
- Bristol-Myers Squibb made up 0.2% of Wealth Group's portfolio in Q2 2026, its #68 holding.
- Wealth Group first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 6 quarters since.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.